To address this limitation, the Berns Lab has developed specific Cre viruses to initiate lung cancer specifically within the surfactant protein C (SPC) cell or the Clara cell antigen 10 (CC10) cell [65, 66] and are commercially available. Here, SFTPC is linked to lung carcinoma.